Summit Impact Partners is a venture capital firm dedicated to driving innovation and positive change in the healthcare ecosystem. Our venture studio model focuses on incubating and developing promising biotechnology companies, with AI serving as a crucial success multiplier, at the seed to early clinical Proof-of-Concept.
 

Our mission is to identify and support groundbreaking ideas that have the potential to revolutionize industries and improve human health. By providing strategic funding, mentorship, and resources, we empower entrepreneurs to bring their visionary concepts to life and scale them globally.
 

Our portfolio combines pioneering companies across AI, healthcare and biological innovation. We invest and incubate ventures using AI and Machine Learning to accelerate discoveries – from mini-CAR platforms, RNA therapeutics to precision medicines and vaccines to address significant unmet medical needs.
 

Our team consists of experienced professionals with a proven track record in venture capital and biotechnology with extensive drug development expertise across multiple disease areas - 25+ FDA approved drugs and 8 exits totaling over $6 Billion USD. We bring together diverse expertise and a shared passion for driving innovation and creating value.​

​

​

Join us in shaping the future of human health